The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
don't panic this will be £1 a share very soon, a loss making company with £900 million worth of debt, they have to make £90 mil just to pay their interest, any future cash will be given to the company by Stroll on very favorable terms he will not lose anything here, but he didn't invest to save us lot only for his benefit and he may get the whole lot very soon, this has every right to be valued a 1.5 billion company (not), not to mention the impact of COVID on the order book which will be made clear on wenesday...
not saying they carry no value i am saying value on them can be more difficult to realise which is why i prefer to use tangible assets and no this is not grossly undervalued, that is utter nonsense, even a novice investor could work that out
thank you i've been holding here pre DFS, this has been sat in the bottom draw a fair while
when is the AGM?
wouldn't that be something, i'd love to see that
debt is essential for business but when it sits at 7.4x times EBITDA and the company is loss making then it is a concern, once AML can start turning these orders into cash that will be a step in the right direction and i am hopeful on wednesday there will be no talk of cancellations.. i am not trying to get under the skin of others but i have seen loads of companies drown under their debts and their failure to control them and now really isn't the time to be carrying huge debts as the global economy slows, while i hope AML will turn their attention to their debts i do not think they will paying half of it off in the next year, the company isn't making any money and i can not see that changing yet
check the results for the presentation in which the board explained the use of the cash from the rights issue, most of it has already been spoken for in the coming year, if they are not making money within that time then they will need more of it obviously, as for debt they issued $340 million of notes and their interest expense for the coming year is $90 million, again check the results presentation, i have the transcript in front of me so it is in black and white, for a company not making any money that does not read well, regardless when the debt is due it is still something that needs to be considered it is still 7.4x EBITDA,
yeah and although i am not exactly shouting from the rooftops, strolls investment is partly why i am here, i do expect a turnaround i just feel it will take longer than some seem to think on here and will require more money further down the line
i have a habit of buying and selling to early but given the PM's comments and the fact that SIG sits on loads of cash then i will be holding these until i have at least doubled my money, loads of good reasons to invest here also company intend to use cash from recent asset sale to pay down debt another reason i invested here.. just three reasons, there are many more..